305 related articles for article (PubMed ID: 28218424)
1. p16
Al-Khalaf HH; Nallar SC; Kalvakolanu DV; Aboussekhra A
Mol Carcinog; 2017 Jul; 56(7):1687-1702. PubMed ID: 28218424
[TBL] [Abstract][Full Text] [Related]
2. p53 Deficiency leads to compensatory up-regulation of p16INK4a.
Leong WF; Chau JF; Li B
Mol Cancer Res; 2009 Mar; 7(3):354-60. PubMed ID: 19240179
[TBL] [Abstract][Full Text] [Related]
3. p16(INK4A) positively regulates p21(WAF1) expression by suppressing AUF1-dependent mRNA decay.
Al-Khalaf HH; Aboussekhra A
PLoS One; 2013; 8(7):e70133. PubMed ID: 23894605
[TBL] [Abstract][Full Text] [Related]
4. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
[TBL] [Abstract][Full Text] [Related]
5. P16(INK4A) is implicated in both the immediate and adaptative response of human keratinocytes to UVB irradiation.
Chazal M; Marionnet C; Michel L; Mollier K; Dazard JE; Della Valle V; Larsen CJ; Gras MP; Basset-Séguin N
Oncogene; 2002 Apr; 21(17):2652-61. PubMed ID: 11965538
[TBL] [Abstract][Full Text] [Related]
6. Two mechanisms underlying the loss of p16(Ink4a) function are associated with distinct tumorigenic consequences for WS MEFs escaping from senescence.
Wu X; Jia S; Zhang X; Si X; Tang W; Luo Y
Mech Ageing Dev; 2012 Aug; 133(8):549-55. PubMed ID: 22813853
[TBL] [Abstract][Full Text] [Related]
7. The cyclin-dependent kinase inhibitor p16INK4a physically interacts with transcription factor Sp1 and cyclin-dependent kinase 4 to transactivate microRNA-141 and microRNA-146b-5p spontaneously and in response to ultraviolet light-induced DNA damage.
Al-Khalaf HH; Mohideen P; Nallar SC; Kalvakolanu DV; Aboussekhra A
J Biol Chem; 2013 Dec; 288(49):35511-25. PubMed ID: 24163379
[TBL] [Abstract][Full Text] [Related]
8. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
[TBL] [Abstract][Full Text] [Related]
9. Expression profiles of p53-, p16(INK4a)-, and telomere-regulating genes in replicative senescent primary human, mouse, and chicken fibroblast cells.
Kim H; You S; Farris J; Kong BW; Christman SA; Foster LK; Foster DN
Exp Cell Res; 2002 Jan; 272(2):199-208. PubMed ID: 11777345
[TBL] [Abstract][Full Text] [Related]
10. p16(INK4a) protects against dysfunctional telomere-induced ATR-dependent DNA damage responses.
Wang Y; Sharpless N; Chang S
J Clin Invest; 2013 Oct; 123(10):4489-501. PubMed ID: 24091330
[TBL] [Abstract][Full Text] [Related]
11. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
12. Single-cell analysis of p16(INK4a) and p21(WAF1) expression suggests distinct mechanisms of senescence in normal human and Li-Fraumeni Syndrome fibroblasts.
Mirzayans R; Andrais B; Scott A; Paterson MC; Murray D
J Cell Physiol; 2010 Apr; 223(1):57-67. PubMed ID: 20039273
[TBL] [Abstract][Full Text] [Related]
13. DNA (cytosine-5)-methyltransferase 1 as a mediator of mutant p53-determined p16(ink4A) down-regulation.
Guo Z; Tsai MH; Shiao YH; Chen LH; Wei ML; Lv X; Gius D; Little JB; Mitchell JB; Chuang EY
J Biomed Sci; 2008 Mar; 15(2):163-8. PubMed ID: 18038118
[TBL] [Abstract][Full Text] [Related]
14. The atr protein kinase controls UV-dependent upregulation of p16INK4A through inhibition of Skp2-related polyubiquitination/degradation.
Al-Khalaf HH; Hendrayani SF; Aboussekhra A
Mol Cancer Res; 2011 Mar; 9(3):311-9. PubMed ID: 21270107
[TBL] [Abstract][Full Text] [Related]
15. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
16. Long-term growth arrest of PUVA-treated fibroblasts in G2/M in the absence of p16(INK4a) p21(CIP1) or p53.
Ma W; Hommel C; Brenneisen P; Peters T; Smit N; Sedivy J; Scharffetter-Kochanek K; Wlaschek M
Exp Dermatol; 2003 Oct; 12(5):629-37. PubMed ID: 14705804
[TBL] [Abstract][Full Text] [Related]
17. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo.
Takeuchi S; Takahashi A; Motoi N; Yoshimoto S; Tajima T; Yamakoshi K; Hirao A; Yanagi S; Fukami K; Ishikawa Y; Sone S; Hara E; Ohtani N
Cancer Res; 2010 Nov; 70(22):9381-90. PubMed ID: 21062974
[TBL] [Abstract][Full Text] [Related]
19. Characterization of coordinated immediate responses by p16INK4A and p53 pathways in UVB-irradiated human skin cells.
Abd Elmageed ZY; Gaur RL; Williams M; Abdraboh ME; Rao PN; Raj MH; Ismail FM; Ouhtit A
J Invest Dermatol; 2009 Jan; 129(1):175-83. PubMed ID: 18719612
[TBL] [Abstract][Full Text] [Related]
20. Real-time in vivo imaging of p16Ink4a reveals cross talk with p53.
Yamakoshi K; Takahashi A; Hirota F; Nakayama R; Ishimaru N; Kubo Y; Mann DJ; Ohmura M; Hirao A; Saya H; Arase S; Hayashi Y; Nakao K; Matsumoto M; Ohtani N; Hara E
J Cell Biol; 2009 Aug; 186(3):393-407. PubMed ID: 19667129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
